Rosalind Franklin University Leader in Reproductive Immunology Speaks at the 2025 American Society of Reproductive Medicine Congress
Dr. Joanne Kwak-Kim, director of the university’s Reproductive Medicine and Immunology program and…
News Archive
Helix 51: Hatching a Plan
69色情片鈥檚 bioscience incubator accelerates the development of new therapies
Rosalind Franklin University Neuroscientist Named One of Illinois' Top Researchers of 2025
Dr. EunJung Hwang Recognized Among “Illinois Researchers to Know” by ISTC
Rosalind Franklin University…
Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate…
Rosalind Franklin University Incubator Company Announces Positive Anti-Fibrotic Effects in Lung Disease Model
BLR Bio, a biotechnology company in Rosalind Franklin University’s Helix 51 incubator, announced…
鈥淲e Need to Intervene鈥�: Casting a Spotlight on Vehicular Crashes
Every day across the United States, too many drivers find themselves involved in motor vehicle accidents (MVAs). A startling…
FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Helix 51 Company
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has…
Dr. Erin Howe Awarded Research Grant to Study Molecular Mechanisms Driving Metastatic Breast Cancer
Rosalind Franklin University cancer biologist Erin Howe, PhD, has been awarded a $100,000 grant…
NIH Fast-Track Grant for Novel Therapeutic to Treat Glioblastoma Awarded to Rosalind Franklin University Helix 51 Incubator Company
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has…
NIH Awards $9.8 million in Funding to Rosalind Franklin University Researchers for Projects Related to Brain Function and Diseases, Cancer and Parasitic Infections
Three Rosalind Franklin University scientists have been awarded approximately $9.8 million in funding…